(firstQuint)Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer.

 Evaluation of safety and efficacy of a treatment associating Pegylated Liposomal Doxorubicin + Docetaxel in patients with metastatic breast cancer.

 Patients will receive pyridoxin to prevent cutaneo-mucinous toxicities.

.

 Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer@highlight

Evaluation of safety and efficacy of a treatment associating Pegylated Liposomal Doxorubicin + Docetaxel in patients with metastatic breast cancer